Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Pfizer Inc. (PFE)

43.93 0.81 (1.88%)

10-16 16:03

Open:

43.35

Pre. Close:

43.12

High:

43.98

Low:

43.04

Volume:

20,529,226

Market Cap:

257522M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

44.018 - 44.328

44.328 - 44.569

Low:

42.459 - 42.788

42.788 - 43.044

Close:

43.498 - 44.01

44.01 - 44.408

Technical analysis  (as of: 2018-10-16 4:37:30 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 51.93     One year: 53.51

Support:

Support1: 42.28    Support2: 35.18

Resistance:

Resistance1: 44.46    Resistance2: 45.81

Pivot:

44.23

Moving Averages:

MA(5): 43.63     MA(20): 44.11

MA(100): 39.95     MA(250): 37.59

MACD:

MACD(12,26): 0.37     Signal(12,26,9): 0.60

%K %D:

%K(14,3): 35.48     %D(3): 31.08

RSI:

RSI(14): 52.79

52-Week:

High: 45.81  Low: 33.2  Change(%): 22.6

Average Vol(K):

3-Month: 2084689  10-Days 2466754

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
PFE has closed above bottom band by 39.5%. Bollinger Bands are 37.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-10-15T13:49:33-04:00
FDA issues new guidance aimed at more efficient drug development

2018-10-14T22:32:37-04:00
Catalyst Biosciences: Rare Risk/Reward Opportunity

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Manufacturers - Major

Shares Out. (M)

5862.11

Shares Float (M)

5848.49

% Held by Insiders

% Held by Institutions

75.90

Shares Short (K)

49879

Shares Short Prior Month (K)

Stock Financials

EPS

2.870

EPS Est. Current Year

2.560

EPS Est. Next Year

2.760

EPS Est. Next Quarter

0.560

Forward EPS

3.059

Book Value (p.s.)

3.600

PEG Ratio

1.87

Profit Margin

49.44

Operating Margin

28.72

Return on Assets (ttm)

13.4

Return on Equity (ttm)

34.8

Qtrly Rev. Growth

4.4

Gross Profit (p.s.)

3.542

Sales Per Share

EBITDA (p.s.)

1.544

Qtrly Earnings Growth

26.00

Operating Cash Flow (M)

17480.00

Levered Free Cash Flow (M)

14590.00

Valuation

P/E

15.31

P/E Growth Ratio

0.02

P/BV

12.20

P/S

28698974208.00

P/CF

14.73

Dividend Yield

0.07

Dividends & Splits

Dividend

3.106

Dividend Pay Date

2018-12-03

Ex-Dividend Date

2018-11-08

Forward Dividend

1.360

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.